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Hamman-Rich syndrome, also known as acute interstitial pneumonia, is a rare and fulminant form of idiopathic interstitial lung
disease. It should be considered as a cause of idiopathic acute respiratory distress syndrome. Conﬁrmatory diagnosis requires
demonstration of diﬀuse alveolar damage on lung histopathology. The main treatment is supportive care. It is not clear if
glucocorticoid therapy is eﬀective in acute interstitial pneumonia.We report the caseof a 77-year-old womanwithoutpre-existing
lung disease who initially presented with mild upper respiratory tract infection and then progressed to rapid onset of hypoxic
respiratory failure similar to acute respiratory distress syndrome with unknown etiology. Despite glucocorticoid therapy, she did
not achieve remissionand expired after 35 days of hospitalization.The diagnosis ofacute interstitial pneumonia was supported by
the histopathologicﬁndings on her lung biopsy.
1.Introduction
Acute interstitial pneumonia (AIP) or Hamman Rich syn-
drome is a rare and fulminant form of lung injury, orig-
inally described by Hamman and Rich in 1935 [1]. It is
an interstitial lung disease characterized by rapid onset
of respiratory failure, similar to acute respiratory distress
syndrome (ARDS) with diﬀuse alveolar damage (DAD) on
lung biopsy specimens.
While the mechanism of the interstitial pneumonia
remains elusive, recent studies have suggested possible
pathogenetic mechanisms. Speciﬁcally, both natural killer
cells and chemokines such as interleukin-18 and interleukin-
2 may play important roles in the evolution of acute
cell injury into unremitting ﬁbrosis speciﬁcally through
abnormal wound repair [2].
The clinical presentation of AIP, as noted in several
case series, has been reported in the literature [3–6]. The
onset of the disease is usually abrupt, with a prodromal
illness that lasts 1 to 2 weeks prior to presentation [6, 7].
The most common clinical symptoms are fever, cough, and
shortness of breath [6]. Further, AIP is characterized by the
rapiddevelopmentofacuterespiratory failureinapreviously
healthy individual without a history of lung disease. It is not
associated with cigarette smoking and occurs with roughly
equalfrequencyinmenandwomen.Themajority ofpatients
are between 50 and 55 years of age [3, 6, 7].
Plain chest radiographic studies of AIP reveal a dif-
fuse, bilateral, air-space opaciﬁcation pattern, and high-
resolution-computed tomography (HRCT) of the chest
shows bilateral, patchy, symmetric areas of ground glass
attenuation. Thus, AIP closely resembles ARDS both clin-
ically and radiologically [8]. In fact, the current accepted
criteria for the diagnosis of AIP include (1) a clinical syn-
drome of idiopathic ARDS and (2) pathologic conﬁrmation
of organizing DAD. Therefore, an open or thoracoscopic
lung biopsy is required to conﬁrm the diagnosis.
According to the American Thoracic Society and Euro-
pean Respiratory Society International Multidisciplinary
Consensus Classiﬁcation of the Idiopathic Interstitial Pneu-
monias, Lung biopsies from patients with AIP typically
shows diﬀuse involvement, although there may be variation
in the severity of the changes among diﬀerent histologic
ﬁelds. The exudative phase shows edema, hyaline mem-
branes, and acute interstitial inﬂammation. The organizing2 Case Reports in Medicine
phase shows loose organizing ﬁbrosis, mostly within alveolar
septa and type II pneumocyte hyperplasia [9].
Generally, the primary focus of therapy is supportive
care includingsupplementaloxygenand ventilatory support.
Several reports have reported beneﬁt from the use of glu-
cocorticoids, in the treatment of AIP, but others contradict
this ﬁnding [6]. Alternative immunosuppressive therapies
(e.g., vincristine, cyclophosphamide, cyclosporine, and aza-
thioprine) and lung transplantation have been reported in
case series of AIP, with limited success [3, 10, 11].
Even with intensive treatment, including mechanical
ventilation, the mortality from AIP remains high (>60
percent), and the majority of patients die within six months
of presentation [6]. Notably, survivors of AIP did not expe-
rience recurrence and enjoyed complete or near complete
recovery of lung function [12, 13].
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hypoxic respiratory failure. Notably, the disease progression
was not reversed by either mechanical ventilation or intra-
venous steroid therapy, and the patient expired after 35 days
of hospitalization.
2.CasePresentation
A 77-year-old woman with a past medical history of diabetes
mellitus type 1, polymyalgia rheumatica, gastroesophageal
reﬂux disease and hypertension, was brought to the emer-
gency department after falling on the ﬂoor, without loss of
consciousness. This was precededby sore throat and lethargy
for 3 days. Her symptoms were associated with a slight
cough but she denied fever, chills, or shortness of breath.
Upon presentation, she was afebrile, without tachypnea, or
oxygendesaturationon roomair. Lungexamination revealed
scattered rhonchi bilaterally. Chest radiograph showed no
obvious pulmonary disease. She was admitted with an
initial diagnosis of near syncope and mild upper respiratory
infection. She was treated with azithromycin intravenously,
with anticipated discharge home in 24 to 48 hours. After 48
hours of hospitalization, her clinical course was complicated
by sudden onset shortness of breath and hypoxemia of
unclear etiology. A repeat chest radiograph revealed acute
wide spread pulmonary inﬁltrates, which represented a
signiﬁcant change from the prior study (Figure 1). Diuretics
were started with a presumptive diagnosis of congestive
heart failure. However, because she had a normal B-type
natriuretic peptide level, and normal echocardiogram, a
primary pulmonary process was suspected. High-resolution
computed tomography (HRCT) of the chest revealed diﬀuse
ground glass opacities throughout the lung ﬁelds, with
bilateral traction bronchiectasis (Figure 2). Video-assisted
thoracoscopic surgery with lung biopsy was performed
on hospital day 19. The lungs revealed diﬀuse alveolar
wall thickening with proliferating connective tissue, for-
mation of hyaline membranes, and type II pneumocyte
hyperplasia (Figure 3) compatible with DAD pattern: mixed
exudativeandorganizingphase.Microbiologicinvestigations
for infectious pathogens, including those on lung biopsy
specimen, were negative. She was transferred to intensive
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Figure 1: Chest radiograph showed acute bilateral pulmonary
inﬁltration, more conﬂuent in the areas of the right upper and
bilateral lower lobes.
care unit secondary to severe acute hypoxic respiratory
failure, Pao2/Fio2 ratio of 89, because she could not be
extubated after the procedure. She received ventilation in the
volume assist-control mode, with a positive-end expiratory
pressure (PEEP) of 5–8cm H2O and tidal volume of 6mL
per measured body weight. Intravenous methylprednisolone
60mg every 6 hours was given for the treatment of AIP, but
the steroids dose was later tapered down. Despite initiation
of intravenous glucocorticoid and high concentration of
oxygen, she remained intubated for 5 weeks. Her clinical
situation deteriorated further with the developmentof sepsis
and acute kidney injury, and she eventually expired after 35
days of hospitalization.
3.Discussion
Our patient presented at an older age than most of the
patients with AIP reported previously. She had the clinical
and radiological proﬁle of AIP. She had sudden onset and
rapid progression of her symptoms, which helped to diﬀer-
entiate AIP from other forms of idiopathic interstitial pneu-
monia in which duration of symptoms is usually in months
to years [3, 14]. HRCT of the chest revealed diﬀuse ground
glass opacities and bronchial dilatation with architectural
distortion, which are the most common ﬁndings [15]. The
diagnosis was conﬁrmed by the histological ﬁnding of DAD
pattern seen on lung biopsy specimen. Infectious etiology
was excluded on the basis of microbiological investigations.
Onerecentstudyreportedhighersurvivalrateswithearly
aggressive diagnostic approach, lung-protective mechanical
ventilation, and the early institution of immunosuppressive
therapy [16].
Our patient received lung-protective mechanical ven-
tilation with low tidal volume and moderately high of
PEEP. It is possible that the unsuccessful remission seen
in our patient may have been inﬂuenced by the delayed
diagnosis: 19 days compared to the mean duration fromCase Reports in Medicine 3
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Figure 2: High resolution CT of the chest showed diﬀuse ground
glass opacities mainly involving the upper lobes.
B
C
C
A
B
Figure 3: Histopathology showed diﬀuse alveolar damage pattern-
m i x e de x u d a t i v ea n do r g a n i z i n gp h a s e ,a sd e m o n s t r a t e db yv i d e o -
assisted thoracostomy lung biopsy: showing interstitial edema and
hemorrhage (A), diﬀuse alveolar wall thickening by proliferating
connective tissue, formation of hyaline membranes, (B) and type II
pneumocyte hyperplasia (C), (hematoxylin- eosin stain) (original
× 100).
admission to diagnosis of 3.5 days from previous series
which have been associated with higher survival rates [16].
Our patient received intravenous glucocorticoid, one of
the recommended treatments [7], although there are no
convincing data to support this practice [17]. Eﬀectiveness
of steroids is also probably dependent on early diagnosis, the
extent of ﬁbrosis, and the ratio of inﬂammation to ﬁbrosis
at the time of diagnosis. We believed that delayed treatment
may not lead to a good clinical response and the addition of
immunosuppressive therapy, such as cyclophosphamide or
vincristine, is also notlikelytoaﬀectthenatural courseof the
latestage ofthedisease especially with extensive ﬁbrosis [17].
Our patient was severely ill, with Pao2/Fio2 of 89:
severe disease associated with a high mortality rate [3, 17].
Ichikado et al. noticed a close correlation between radiologi-
cal ﬁndings and pathologic phases of DAD.They determined
that patients who have the radiological ﬁndings of traction
bronchiectasis, as seen in our patient, have more severe
disease and a higher mortality [5, 18].
To date, there are no published guidelines on the man-
agement of AIP. In summary, despite mechanical ventilation,
supportive care, and corticosteroid therapy, our patient
did not achieve remission and expired within 35 days of
hospitalization. This conﬁrms the high mortality rate in AIP
similar to that reported in previous series.
4.Conclusion
Sudden onset acute hypoxic respiratory failure in a patient
withoutpre-existing lungdisease shouldsuggest thepresence
of interstitial lung disease. AIP should be considered in the
diﬀerential diagnosis of ARDS, when the etiology remains
unclear. The main treatment is supportive care. Mechanical
ventilation is often required. Although early glucocorticoid
orimmunosuppressivetherapyhasbeenreportedtoimprove
the clinical outcomes, its eﬃcacy is yet to be proven.
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